Amrize Ltd (NYSE:AMRZ – Get Free Report) CTO Roald Brouwer acquired 3,000 shares of the company’s stock in a transaction dated Wednesday, March 11th. The stock was purchased at an average cost of $58.72 per share, for a total transaction of $176,160.00. Following the purchase, the chief technology officer directly owned 16,257 shares in the company, valued at approximately $954,611.04. This represents a 22.63% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this link.
Amrize Price Performance
AMRZ stock traded down $1.14 during trading hours on Wednesday, hitting $58.03. 1,191,449 shares of the stock traded hands, compared to its average volume of 3,548,729. The stock has a 50-day simple moving average of $57.80 and a 200 day simple moving average of $53.59. The company has a market cap of $32.10 billion and a P/E ratio of 23.60. Amrize Ltd has a one year low of $44.12 and a one year high of $65.94. The company has a current ratio of 1.64, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37.
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The company’s revenue was down .4% compared to the same quarter last year.
Institutional Investors Weigh In On Amrize
Analyst Upgrades and Downgrades
AMRZ has been the subject of several recent research reports. Wells Fargo & Company increased their target price on shares of Amrize from $59.00 to $66.00 and gave the company an “overweight” rating in a research note on Thursday, February 19th. Vertical Research assumed coverage on shares of Amrize in a research report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target on the stock. Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price objective on shares of Amrize in a research report on Thursday, December 18th. Oppenheimer reissued an “outperform” rating and set a $70.00 price objective (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a report on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $64.14.
Get Our Latest Stock Report on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
